bromodeoxyuridine has been researched along with Glaucoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchshofer, R; Jünemann, A; Kottler, UB; Kruse, FE; Ohlmann, A; Ohlmann, AV; Schlötzer-Schrehardt, U | 1 |
| Horner, PJ; Inman, DM | 1 |
2 other study(ies) available for bromodeoxyuridine and Glaucoma
| Article | Year |
|---|---|
SPARC is expressed in scars of the Tenon's capsule and mediates scarring properties of human Tenon's fibroblasts in vitro.
Topics: Animals; Bromodeoxyuridine; Cell Proliferation; Cicatrix; Collagen; Extracellular Matrix; Fibroblasts; Gene Expression Regulation; Glaucoma; Humans; Immunohistochemistry; Osteonectin; Rats; Tenon Capsule; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Wound Healing | 2011 |
Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma.
Topics: Aging; Animals; Astrocytes; Biomarkers; Bromodeoxyuridine; Cell Count; Cell Division; Cell Proliferation; Chronic Disease; Disease Models, Animal; Glaucoma; Glial Fibrillary Acidic Protein; Gliosis; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microglia; Neuroglia; Retina; Retinal Degeneration; RNA, Messenger; Up-Regulation | 2007 |